431 related articles for article (PubMed ID: 24330406)
1. Prediction of pregabalin-mediated pain response by severity of sleep disturbance in patients with painful diabetic neuropathy and post-herpetic neuralgia.
Vinik A; Emir B; Parsons B; Cheung R
Pain Med; 2014 Apr; 15(4):661-70. PubMed ID: 24330406
[TBL] [Abstract][Full Text] [Related]
2. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin.
Vinik A; Emir B; Cheung R; Whalen E
Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708
[TBL] [Abstract][Full Text] [Related]
3. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
5. Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia.
Parsons B; Emir B; Knapp L
Am J Ther; 2015; 22(4):257-68. PubMed ID: 25272094
[TBL] [Abstract][Full Text] [Related]
6. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
Roth T; van Seventer R; Murphy TK
Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: a Canadian perspective.
Tarride JE; Gordon A; Vera-Llonch M; Dukes E; Rousseau C
Clin Ther; 2006 Nov; 28(11):1922-34. PubMed ID: 17213013
[TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
9. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
[TBL] [Abstract][Full Text] [Related]
12. Time to onset of neuropathic pain reduction: A retrospective analysis of data from nine controlled trials of pregabalin for painful diabetic peripheral neuropathy and postherpetic neuralgia.
Sharma U; Griesing T; Emir B; Young JP
Am J Ther; 2010; 17(6):577-85. PubMed ID: 20393345
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.
Baron R; Brunnmüller U; Brasser M; May M; Binder A
Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109
[TBL] [Abstract][Full Text] [Related]
14. Pregabalin treatment for peripheral neuropathic pain: a review of safety data from randomized controlled trials conducted in Japan and in the west.
Ogawa S; Satoh J; Arakawa A; Yoshiyama T; Suzuki M
Drug Saf; 2012 Oct; 35(10):793-806. PubMed ID: 22967187
[TBL] [Abstract][Full Text] [Related]
15. Reliability, validity, and responsiveness of the daily sleep interference scale among diabetic peripheral neuropathy and postherpetic neuralgia patients.
Vernon MK; Brandenburg NA; Alvir JM; Griesing T; Revicki DA
J Pain Symptom Manage; 2008 Jul; 36(1):54-68. PubMed ID: 18411009
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
[TBL] [Abstract][Full Text] [Related]
17. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial.
Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M;
Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123
[TBL] [Abstract][Full Text] [Related]
18. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial.
Gilron I; Wajsbrot D; Therrien F; Lemay J
Clin J Pain; 2011; 27(3):185-93. PubMed ID: 21178603
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trial.
Stacey BR; Dworkin RH; Murphy K; Sharma U; Emir B; Griesing T
Pain Med; 2008 Nov; 9(8):1202-8. PubMed ID: 18346060
[TBL] [Abstract][Full Text] [Related]
20. Dose-response of pregabalin for diabetic peripheral neuropathy, postherpetic neuralgia, and fibromyalgia.
Arnold LM; McCarberg BH; Clair AG; Whalen E; Thomas N; Jorga A; Pauer L; Vissing R; Park PW
Postgrad Med; 2017 Nov; 129(8):921-933. PubMed ID: 28967801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
